Dalibor Sames

Dalibor Sames

Fondatore presso Gilgamesh Pharmaceuticals, Inc.

Health Technology

Provenienza dei contatti di primo grado di Dalibor Sames

EntitàTipo di entitàSettore Industriale
9
Holding Company Pharmaceuticals: Major 9
5
Subsidiary Biotechnology 5

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Dalibor Sames tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
CUBIC CORPORATION Electronic Equipment/Instruments

Amy Kruse

Chief Tech/Sci/R&D Officer

IDEXX LABORATORIES, INC. Medical Specialties

Errol de Souza

Director/Board Member

Pharmaceuticals: Major

Errol de Souza

Chief Executive Officer

Pharmaceuticals: Major

Chad E. Beyer

Corporate Officer/Principal

OPIANT PHARMACEUTICALS, INC. Pharmaceuticals: Major

Phil Skolnick

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Chad E. Beyer

Chief Tech/Sci/R&D Officer

Financial Conglomerates

Dakin Sloss

Director/Board Member

Pharmaceuticals: Major

Errol de Souza

Chief Tech/Sci/R&D Officer

Stanford University College/University

Dakin Sloss

Undergraduate Degree

BIONOMICS LIMITED Pharmaceuticals: Generic

Errol de Souza

Srinivas Rao

Chairman

Director/Board Member

Pharmaceuticals: Major

Errol de Souza

Corporate Officer/Principal

College/University

Amy Kruse

Graduate Degree

Long Island University College/University

Phil Skolnick

Undergraduate Degree

Louisiana State University College/University

Chad E. Beyer

Doctorate Degree

National Institute on Drug Abuse General Government

Phil Skolnick

Corporate Officer/Principal

Uniformed Services University of the Health Sciences College/University

Phil Skolnick

Corporate Officer/Principal

Pharmaceuticals: Major

Errol de Souza

President

Investment Managers

Amy Kruse

Chief Investment Officer

Rutgers Business School College/University

Chad E. Beyer

Masters Business Admin

Packaged Software

Dakin Sloss

Chief Executive Officer

Medical/Nursing Services

Errol de Souza

Chief Executive Officer

Medical Specialties

Dakin Sloss

Amy Kruse

Director/Board Member

Director/Board Member

ALBIREO PHARMA, INC. Pharmaceuticals: Major

Errol de Souza

Chief Executive Officer

Miscellaneous Commercial Services

Dakin Sloss

Director/Board Member

Electrical Products

Dakin Sloss

Director/Board Member

Hospital/Nursing Management

Phil Skolnick

Corporate Officer/Principal

Industrial Machinery

Dakin Sloss

Director/Board Member

University of Illinois At Urbana–Champaign College/University

Amy Kruse

Doctorate Degree

George Washington University School of Medicine & Health College/University

Phil Skolnick

Doctorate Degree

Packaged Software

Amy Kruse

Director/Board Member

Investment Managers

Dakin Sloss

Amy Kruse

Founder

Private Equity Investor

Telecommunications Equipment

Dakin Sloss

Director/Board Member

Medical/Nursing Services

Srinivas Rao

Jonathan Sporn

Director/Board Member

Founder

CYCLERION THERAPEUTICS, INC. Pharmaceuticals: Major

Errol de Souza

Chairman

ROYALTY PHARMA PLC Pharmaceuticals: Major

Errol de Souza

Director/Board Member

Aerospace & Defense

Dakin Sloss

Director/Board Member

Data Processing Services

Dakin Sloss

Director/Board Member

VAXXINITY, INC. Biotechnology

Dakin Sloss

Director/Board Member

AXONPRIME INFRASTRUCTURE ACQUISITION CORPORATION Financial Conglomerates

Dakin Sloss

Founder

Medical Specialties

Amy Kruse

Director/Board Member

Beverages: Non-Alcoholic

Dakin Sloss

Director/Board Member

Information Technology Services

Dakin Sloss

Director/Board Member

Sattva Science LLC

Amy Kruse

Founder

Building Products

Dakin Sloss

Director/Board Member

Packaged Software

Dakin Sloss

Chief Executive Officer

California Common Sense

Dakin Sloss

Corporate Officer/Principal

Statistiche

Distribuzione geografica

Stati Uniti 48
Australia 2
Spagna 2
Francia 2

Settori

Health Technology 17
Consumer Services 9
Technology Services 8
Finance 5
Electronic Technology 4

Posizioni

Director/Board Member 44
Corporate Officer/Principal 17
Founder 16
Chief Tech/Sci/R&D Officer 15
Chief Executive Officer 13
-40% Proroga eccezionale: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA